Afstyla 250 IE

Afstyla 250 IE is a medicine authorised by Swissmedic under authorisation number 66030. The authorisation holder is CSL Behring Lengnau AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 April 2017 and the authorisation is valid without a time limit. ATC code B02BD02 places the medicine in the group Antihemorrhagics.

  • Dispensing category B
  • Authorisation number 66030
  • ATC B02BD02
  • Biotechnological medicines
Authorisation data
Authorisation number66030
NameAfstyla 250 IE
Full nameAfstyla 250 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Authorisation holderCSL Behring Lengnau AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeB02BD02
First authorisation07 April 2017
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Afstyla 250 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB07 April 2017
3Afstyla 500 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB07 April 2017
4Afstyla 1000 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB07 April 2017
5Afstyla 1500 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB07 April 2017
6Afstyla 2000 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB07 April 2017
7Afstyla 2500 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB07 April 2017
8Afstyla 3000 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB07 April 2017

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
10500I.E.B02BD0206.01.1.B
111000I.E.B02BD0206.01.1.B
132000I.E.B02BD0206.01.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Afstyla 250 IE authorised in Switzerland?

Yes. Afstyla 250 IE is authorised by Swissmedic under authorisation number 66030, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Afstyla 250 IE have?

Afstyla 250 IE is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Afstyla 250 IE?

The authorisation holder is CSL Behring Lengnau AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com